Skip to main content

Table 4 Fleas recovered in premises flea traps in naturally infested homes when dogs were administered either fluralaner or afoxolaner chews

From: Evaluation of fluralaner and afoxolaner treatments to control flea populations, reduce pruritus and minimize dermatologic lesions in naturally infested dogs in private residences in west central Florida USA

Treatment group

# homes

 

Days post-Treatmenta

   

Day 0

Day 7

Day 14

Day 21

Day 28–30

Day 40–45

Day 54–60

Day 82–86

Fluralanerb

17

Geomeand

19.2

1.5

0.5

1.2

0.1

0.1

0.0

0.0

 

% controle

 

92.4

97.3

93.9

99.6

99.7

99.8

100.0

  

range

(6–122)

(0–8)

(0–5)

(0–4)

(0–1)

(0–2)

(0–1)

(0–0)

Afoxolanerc

17

Geomean

14.0

1.9

1.7

1.4

0.5

0.3

0.3

0.1

 

% control

 

86.5

88.0

90.2

96.7

98.2

97.8

98.9

 

range

(6–167)

(0–10)

(0–12)

(0–23)

(0–26)

(0–11)

(0–8)

(0–1)

  1. a In both groups, dogs were treated on day 0. In the afoxolaner group dogs were also treated once between days 28–30 and once between days 54–60
  2. bDogs were orally administered fluralaner chews (Bravecto® Merck Animal Health) according to label directions
  3. cDogs were orally administered afoxolaner chewables (NexGard® Merial, Inc.) according to label directions
  4. dGeometric mean numbers of fleas recovered in two intermittent light flea traps averaged within households
  5. e{(Day 0 geometric mean trap flea counts—day x geometric mean trap flea counts)/day 0 geometric mean trap flea counts)} x 100
Back to article page

Parasites & Vectors

ISSN: 1756-3305

Contact us